Update on the Management of High-Risk Penetrating Keratoplasty
- PMID: 28959505
- PMCID: PMC5612422
- DOI: 10.1007/s40135-017-0119-2
Update on the Management of High-Risk Penetrating Keratoplasty
Abstract
Purpose of review: In this article, we review the indications and latest management of high-risk penetrating keratoplasty.
Recent findings: Despite the immune-privilege status of the cornea, immune-mediated graft rejection still remains the leading cause of corneal graft failure. This is particularly a problem in the high-risk graft recipients, namely patients with previous graft failure due to rejection and those with inflamed and vascularized corneal beds. A number of strategies including both local and systemic immunosuppression are currently used to increase the success rate of high-risk corneal grafts. Moreover, in cases of limbal stem cell deficiency, limbal stem cells transplantation is employed.
Summary: Corticosteroids are still the top medication for prevention and treatment in cases of corneal graft rejection. Single and combined administration of immunosuppressive agents e.g. tacrolimus, cyclosporine and mycophenolate are promising adjunctive therapies for prolonging graft survival. In the future, cellular and molecular therapies should allow us to achieve immunologic tolerance even in high-risk grafts.
Keywords: Cornea; Graft rejection; High risk; Immunosuppressive drugs; Ocular surface disorder; Penetrating keratoplasty.
Conflict of interest statement
Compliance with Ethical Guidelines Conflict of Interest Ali Djalilian, Sayena Jabbehdari, Alireza Baradaran Rafii, Ghasem Yazdanpanah, Pedram Hamrah and Edward Holland declare no conflict of interest. Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors.
Figures



References
-
- Chong EM, Dana MR. Graft failure IV. Immunologic mechanisms of corneal transplant rejection. Int Ophthalmol. 2008;28:209–22. - PubMed
-
- Reis A, Reinhard T. Cornea and External Eye Disease. Springer; 2006. Current systemic immunosuppressive strategies in penetrating keratoplasty; pp. 109–22.
-
- The collaborative corneal transplantation studies (CCTS) Effectiveness of histocompatibility matching in high-risk corneal transplantation. The Collaborative Corneal Transplantation Studies Research Group. Arch Ophthalmol. 1992;110:1392–403. - PubMed
-
- Guilbert E, Bullet J, Sandali O, Basli E, Laroche L, Borderie VM. Long-term rejection incidence and reversibility after penetrating and lamellar keratoplasty. Am J Ophthalmol. 2013;155:560–9. e2. - PubMed
-
- Borderie VM, Sandali O, Bullet J, Gaujoux T, Touzeau O, Laroche L. Long-term results of deep anterior lamellar versus penetrating keratoplasty. Ophthalmology. 2012;119:249–55. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials